NAIL vs. CURE
NAIL (Direxion Daily Homebuilders & Supplies Bull 3X ETF) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - NAIL is a Building & Construction fund tracking the Dow Jones U.S. Select Home Construction Index, while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, NAIL returned 2.80%/yr vs 13.35%/yr for CURE. Their 0.42 correlation means their historical movements had little consistent relationship. NAIL charges 0.96%/yr vs 0.94%/yr for CURE.
Performance
NAIL vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NAIL achieves a -25.11% return, which is significantly lower than CURE's 6.99% return. Over the past 10 years, NAIL has underperformed CURE with an annualized return of 2.80%, while CURE has yielded a comparatively higher 13.35% annualized return.
NAIL
- 1D
- -3.77%
- 1M
- -24.78%
- 6M
- -35.02%
- YTD
- -25.11%
- 1Y
- -40.69%
- 3Y*
- -23.69%
- 5Y*
- -14.77%
- 10Y*
- 2.80%
- ALL TIME*
- -0.25%
CURE
- 1D
- -1.72%
- 1M
- -3.56%
- 6M
- 9.07%
- YTD
- 6.99%
- 1Y
- 68.66%
- 3Y*
- 7.13%
- 5Y*
- 0.86%
- 10Y*
- 13.35%
- ALL TIME*
- 24.24%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $8.40M | $9.61M | $9.25M | |
| $44.87M | $43.82M | $62.70M |
NAIL vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NAIL Direxion Daily Homebuilders & Supplies Bull 3X ETF | -25.11% | -40.43% | -22.83% | 259.61% | -75.23% | 168.20% | -32.08% | 184.63% | -73.96% | 268.71% |
CURE Direxion Daily Healthcare Bull 3x Shares | 6.99% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between NAIL and CURE is 0.39, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.39 |
Correlation (3Y) Balances recent behavior with more history. | 0.46 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.47 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.43 |
Correlation (All Time) Calculated using the full available price history since Aug 19, 2015 | 0.42 |
NAIL vs. CURE - Sectors Allocation Comparison
Sectors
NAIL
CURE
Consumer Cyclical
-
Industrials
-
Basic Materials
-
Real Estate
-
Communication Services
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Healthcare
-
Technology
-
Utilities
-
-
Consumer Cyclical
NAIL
CURE
-
Industrials
NAIL
CURE
-
Basic Materials
NAIL
CURE
-
Real Estate
NAIL
CURE
-
Communication Services
NAIL
-
CURE
-
Consumer Defensive
NAIL
-
CURE
-
Energy
NAIL
-
CURE
-
Financial Services
NAIL
-
CURE
-
Healthcare
NAIL
-
CURE
Technology
NAIL
-
CURE
Utilities
NAIL
-
CURE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NAIL vs. CURE — Risk / Return Rank
NAIL
CURE
NAIL vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Homebuilders & Supplies Bull 3X ETF (NAIL) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NAIL | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.97 | ||
| Sortino ratioReturn per unit of downside risk | -2.47 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.26 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | 2.31 | -2.84 |
| Martin ratioReturn relative to average drawdown | -0.82 | 5.20 | -6.02 |
Loading charts...
Drawdowns
NAIL vs. CURE - Drawdown Comparison
The maximum NAIL drawdown since its inception was -93.75%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for NAIL and CURE.
Loading charts...
Drawdown Indicators
| NAIL | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.75% | -69.19% | -24.56% |
Max Drawdown (1Y)Largest decline over 1 year | -67.85% | -31.10% | -36.75% |
Max Drawdown (3Y)Largest decline over 3 years | -82.09% | -51.93% | -30.16% |
Max Drawdown (5Y)Largest decline over 5 years | -84.40% | -52.23% | -32.17% |
Max Drawdown (10Y)Largest decline over 10 years | -93.75% | -69.19% | -24.56% |
Current DrawdownCurrent decline from peak | -78.60% | -15.08% | -63.52% |
Average DrawdownAverage peak-to-trough decline | -44.24% | -18.17% | -26.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 43.97% | 13.82% | +30.15% |
Volatility
NAIL vs. CURE - Volatility Comparison
Direxion Daily Homebuilders & Supplies Bull 3X ETF (NAIL) has a higher volatility of 26.41% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 17.62%. This indicates that NAIL's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NAIL | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.41% | 17.62% | +8.79% |
Volatility (6M)Calculated over the trailing 6-month period | 65.39% | 35.23% | +30.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.99% | 46.92% | +41.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 88.09% | 44.69% | +43.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 89.81% | 49.85% | +39.96% |
NAIL vs. CURE - Expense Ratio Comparison
NAIL has a 0.96% expense ratio, which is higher than CURE's 0.94% expense ratio.
Dividends
NAIL vs. CURE - Dividend Comparison
NAIL's dividend yield for the trailing twelve months is around 0.83%, less than CURE's 1.06% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.06% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
NAIL Direxion Daily Homebuilders & Supplies Bull 3X ETF | 0.83% | 1.55% | 0.63% | 0.22% | 0.00% | 0.00% | 0.01% | 0.17% | 0.35% | 1.25% |
Frequently Asked Questions
NAIL and CURE have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NAIL has higher volatility (26.41%) compared to CURE (17.62%). In terms of maximum drawdown, NAIL dropped -93.75% vs CURE's -69.19%.
On 10-year performance, CURE leads with 13.35% vs 2.80% for NAIL. On fees, CURE is cheaper at 0.94% per year. On volatility, CURE has been the lower-risk option at 17.62%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.35% return vs 2.80%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE is cheaper with a 0.94% expense ratio, compared with 0.96% for NAIL.
CURE has the higher dividend yield at 1.06%, compared with 0.83% for NAIL.
NAIL is categorized as Building & Construction, while CURE is Leveraged Equities. NAIL tracks Dow Jones U.S. Select Home Construction Index, while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 0.96% for NAIL and 0.94% for CURE.
CURE currently has the higher Sharpe Ratio (1.56 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NAIL and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer